TY  - RPRT
TI  - Mid-year at the FDA highlights permanent problem.
AU  - Ken Howard
PY  - 2004
DO  - 10.1038/nrd1486
UR  - https://pubmed.ncbi.nlm.nih.gov/15317145/
ID  - 15317145
ER  -